FDA Accepts Biologics License Application for Sobi's NASP for Patients with Uncontrolled Gout ...Middle East

Submission includes results of the pivotal DISSOLVE I and II studies NASP PDUFA date set for 27 June 2026 STOCKHOLM, Sept. 10, 2025 /PRNewswire/ -- Sobi® (STO: SOBI), a global biopharmaceutical company dedicated to delivering innovative treatments for patients with rare diseases, today...

Hence then, the article about fda accepts biologics license application for sobi s nasp for patients with uncontrolled gout was published today ( Wednesday 10/09/2025 - 09:59 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Accepts Biologics License Application for Sobi's NASP for Patients with Uncontrolled Gout )

Also on site :

• Natural gas line rupture stops traffic on 5 Freeway in Castaic
• 30–35 terrorists on radar: Army steps up counterterror ops in J&K; intense vigil amid 'Chillai Kalan'
• Nine Years After Carrie Fisher Died, Billie Lourd Says Mom “Lives on Through Joy” With Kids, Dad Bryan Lourd